BioVie stock dips on pricing $12M securities offering

BioVie (NASDAQ:BIVI) has priced a public offering of 6 million units at $2.00 per unit, raising approximately $12 million in gross proceeds.

Each unit includes one share of common stock and one warrant, or pre-funded units in lieu thereof, with each pre-funded unit consisting of one pre-funded warrant and one warrant.

The warrants are immediately exercisable at $2.50 per share and expire five years from issuance. Each pre-funded warrant will be immediately exercisable, will entitle the holder to purchase one share of common stock and may be exercised at any time until exercised in full.

The warrants (BIVIW) are expected to begin trading on Nasdaq on August 8, 2025. The common stock and warrants must be bought together but will be issued separately.

BioVie has also given underwriters a 45-day option to purchase up to 900,000 additional securities to cover any over-allotments.

Proceeds will be used for working capital and general corporate purposes. The offering is expected to close on August 11, 2025, subject to customary conditions.

BIVI fell 7.9% premarket on Friday.